While the detected colloidal features are away from the desired for in vivo interventions3, the demonstrated specificity to FGF2 put the employed scFv design as a potential template to be further used to engineer a monomeric product for therapeutic purposes and also for addressing the significance of FGF2 inhibition on tumor growth. The gene discussed is FGF2; the disease is neoplasm.